Literature DB >> 34372862

Dynamically adjusted strategy in response to developments in the COVID-19 pandemic as a new normal.

Weifeng Shen1.   

Abstract

Presently, the developments of COVID-19 situation in different countries and regions have clearly differentiated. Due to differences in resources, infrastructure, and awareness of epidemic prevention and control, capabilities for COVID-19 prevention and control in various regions have also shown a significant imbalance as the COVID-19 epidemic is entering a new normal. The objectives of this study are to provide dynamically adjusted strategies in response to developments in the COVID-19 pandemic as a new normal. In the face of the new normal, one key is normalizing epidemic prevention and control. As part of this, we should implement precise policies based on the dynamics of the COVID-19 epidemic and particular response needs. In ongoing COVID-19 prevention and control, we must pay attention to new vulnerabilities and new features in the dynamics of the epidemic. In this study, health and government officials can benefit from insights of preparing ourselves for long-term challenges and both certainties and uncertainties in a future facing COVID-19.
© 2021. The Author(s).

Entities:  

Keywords:  COVID-19; Pandemic; Public health; Response; Strategy

Year:  2021        PMID: 34372862     DOI: 10.1186/s12992-021-00746-9

Source DB:  PubMed          Journal:  Global Health        ISSN: 1744-8603            Impact factor:   4.185


  54 in total

1.  The emerging plasticity of SARS-CoV-2.

Authors:  Kevin D McCormick; Jana L Jacobs; John W Mellors
Journal:  Science       Date:  2021-03-26       Impact factor: 47.728

2.  Coronavirus variants are spreading in India - what scientists know so far.

Authors:  Gayathri Vaidyanathan
Journal:  Nature       Date:  2021-05       Impact factor: 49.962

3.  Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials.

Authors:  Shengli Xia; Kai Duan; Yuntao Zhang; Dongyang Zhao; Huajun Zhang; Zhiqiang Xie; Xinguo Li; Cheng Peng; Yanbo Zhang; Wei Zhang; Yunkai Yang; Wei Chen; Xiaoxiao Gao; Wangyang You; Xuewei Wang; Zejun Wang; Zhengli Shi; Yanxia Wang; Xuqin Yang; Lianghao Zhang; Lili Huang; Qian Wang; Jia Lu; Yongli Yang; Jing Guo; Wei Zhou; Xin Wan; Cong Wu; Wenhui Wang; Shihe Huang; Jianhui Du; Ziyan Meng; An Pan; Zhiming Yuan; Shuo Shen; Wanshen Guo; Xiaoming Yang
Journal:  JAMA       Date:  2020-09-08       Impact factor: 56.272

4.  Vaccine Breakthrough Infections with SARS-CoV-2 Variants.

Authors:  Ezgi Hacisuleyman; Caryn Hale; Yuhki Saito; Nathalie E Blachere; Marissa Bergh; Erin G Conlon; Dennis J Schaefer-Babajew; Justin DaSilva; Frauke Muecksch; Christian Gaebler; Richard Lifton; Michel C Nussenzweig; Theodora Hatziioannou; Paul D Bieniasz; Robert B Darnell
Journal:  N Engl J Med       Date:  2021-04-21       Impact factor: 91.245

5.  Beware of the second wave of COVID-19.

Authors:  Shunqing Xu; Yuanyuan Li
Journal:  Lancet       Date:  2020-04-08       Impact factor: 79.321

6.  An action plan for pan-European defence against new SARS-CoV-2 variants.

Authors:  Viola Priesemann; Rudi Balling; Melanie M Brinkmann; Sandra Ciesek; Thomas Czypionka; Isabella Eckerle; Giulia Giordano; Claudia Hanson; Zdenek Hel; Pirta Hotulainen; Peter Klimek; Armin Nassehi; Andreas Peichl; Matjaz Perc; Elena Petelos; Barbara Prainsack; Ewa Szczurek
Journal:  Lancet       Date:  2021-01-21       Impact factor: 79.321

7.  SnapShot: COVID-19.

Authors:  Blake Oberfeld; Aditya Achanta; Kendall Carpenter; Pamela Chen; Nicole M Gilette; Pinky Langat; Jordan Taylor Said; Abigail E Schiff; Allen S Zhou; Amy K Barczak; Shiv Pillai
Journal:  Cell       Date:  2020-04-30       Impact factor: 41.582

8.  Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China.

Authors:  Jing Lu; Louis du Plessis; Zhe Liu; Verity Hill; Min Kang; Huifang Lin; Jiufeng Sun; Sarah François; Moritz U G Kraemer; Nuno R Faria; John T McCrone; Jinju Peng; Qianling Xiong; Runyu Yuan; Lilian Zeng; Pingping Zhou; Chumin Liang; Lina Yi; Jun Liu; Jianpeng Xiao; Jianxiong Hu; Tao Liu; Wenjun Ma; Wei Li; Juan Su; Huanying Zheng; Bo Peng; Shisong Fang; Wenzhe Su; Kuibiao Li; Ruilin Sun; Ru Bai; Xi Tang; Minfeng Liang; Josh Quick; Tie Song; Andrew Rambaut; Nick Loman; Jayna Raghwani; Oliver G Pybus; Changwen Ke
Journal:  Cell       Date:  2020-04-30       Impact factor: 41.582

9.  Risk for Transportation of Coronavirus Disease from Wuhan to Other Cities in China.

Authors:  Zhanwei Du; Lin Wang; Simon Cauchemez; Xiaoke Xu; Xianwen Wang; Benjamin J Cowling; Lauren Ancel Meyers
Journal:  Emerg Infect Dis       Date:  2020-05-17       Impact factor: 6.883

Review 10.  Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe.

Authors:  Emeline Han; Melisa Mei Jin Tan; Eva Turk; Devi Sridhar; Gabriel M Leung; Kenji Shibuya; Nima Asgari; Juhwan Oh; Alberto L García-Basteiro; Johanna Hanefeld; Alex R Cook; Li Yang Hsu; Yik Ying Teo; David Heymann; Helen Clark; Martin McKee; Helena Legido-Quigley
Journal:  Lancet       Date:  2020-09-24       Impact factor: 79.321

View more
  1 in total

1.  Prevalence and influencing factors of pandemic fatigue among Chinese public in Xi'an city during COVID-19 new normal: a cross-sectional study.

Authors:  Ling Xin; Liuhui Wang; Xuan Cao; Yingnan Tian; Yisi Yang; Kexin Wang; Zheng Kang; Miaomiao Zhao; Chengcheng Feng; Xinyu Wang; Nana Luo; Huan Liu; Qunhong Wu
Journal:  Front Public Health       Date:  2022-09-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.